In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

The Iowa Pharmacy Association is calling for reform from Iowa lawmakers after 29 pharmacies closed last year, including some ...

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

The association says pharmacy benefit managers (PBM’s) are to blame ... calls them anti-competitive middlemen in the pharmacy supply chain that have been allowed to operate largely unregulated.

A bill before the Arkansas legislature would prevent pharmacy benefit managers (PBMs) or insurance companies from obtaining ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...